synthetase < synthetic < syrup

Facettes : Author.f AffOrg.f AffPays.f AffRegion.f AffVille.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]

Ident.	Authors (with country if any)	Title
000152 (2015)	Vitor H. Pomin [Brésil]	A Dilemma in the Glycosaminoglycan‐Based Therapy: Synthetic or Naturally Unique Molecules?
000394 (2012)	Y. Mohammed [Égypte] ; N. A. El-Baky [Égypte] ; N. A. Redwan [Arabie saoudite] ; E. M. Redwan [Égypte, Arabie saoudite]	Expression of human interferon-α8 synthetic gene under PBAD promoter
000469 (2011)	Ekambar R. Kandimalla [États-Unis] ; Sudhir Agrawal [États-Unis]	Modulation of Endosomal Toll-Like Receptor-Mediated Immune Responses by Synthetic Oligonucleotides
000484 (2011)	Michael Liss ; Ralf Wagner [Allemagne]	Gene Synthesis – Enabling Technologies for Synthetic Biology
000649 (2009)	Renée Roodbeen [Pays-Bas] ; Jan C. M. Van Hest [Pays-Bas]	Synthetic cells and organelles: compartmentalization strategies
000650 (2009)	Karen Lienkamp [États-Unis] ; Gregory Tew [États-Unis]	Synthetic Mimics of Antimicrobial Peptides—A Versatile Ring‐Opening Metathesis Polymerization Based Platform for the Synthesis of Selective Antibacterial and Cell‐Penetrating Polymers
000873 (2007)	Janet W. De Beukelaar [Pays-Bas] ; Jan W. Gratama [Pays-Bas] ; Peter A. Sillevis Smitt [Pays-Bas] ; Georges M. Verjans [Pays-Bas] ; Jaco Kraan [Pays-Bas] ; Theo M. Luider [Pays-Bas] ; Peter C. Burgers [Pays-Bas]	The impact of impurities in synthetic peptides on the outcome of T‐cell stimulation assays
000907 (2007)	Peter Timmerman [Pays-Bas] ; Wouter C. Puijk [Pays-Bas] ; Rob H. Meloen [Pays-Bas]	Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS™ technology
000925 (2007)	Cindy Araya [Costa Rica] ; Bruno Lomonte [Costa Rica]	Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms
000A69 (2005)	Philip Ball [Royaume-Uni]	Synthetic biology for nanotechnology
000C35 (2004)	S. Shichijo [Japon] ; N. Keicho [Japon] ; H. T. Long [Viêt Nam] ; T. Quy [Viêt Nam] ; N. C. Phi [Viêt Nam] ; L. D. Ha [Viêt Nam] ; V. V. Ban [Viêt Nam] ; S. Itoyama [Japon] ; C. Hu [Taïwan] ; N. Komatsu [Japon] ; T. Kirikae [Japon] ; F. Kirikae [Japon] ; S. Shirasawa [Japon] ; M. Kaji [Japon] ; T. Fukuda [Japon] ; M. Sata [Japon] ; T. Kuratsuji [Japon] ; K. Itoh [Japon] ; T. Sasazuki [Japon]	Assessment of synthetic peptides of severe acute respiratory syndrome coronavirus recognized by long‐lasting immunity
000C40 (2004)	B. Yasin [États-Unis] ; M. Pang [États-Unis] ; E. A. Wagar [États-Unis]	A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis
000C84 (2003)	Anna Manzano [Royaume-Uni] ; Zahra Mohri [Royaume-Uni] ; Galia Sperber [Royaume-Uni] ; Manfred Ogris [Allemagne] ; Ian Graham [Royaume-Uni] ; George Dickson [Royaume-Uni] ; James S. Owen [Royaume-Uni]	Failure to generate atheroprotective apolipoprotein AI phenotypes using synthetic RNA/DNA oligonucleotides (chimeraplasts)
000D38 (2002)	Roshni Sundaram [États-Unis] ; Naveen K. Dakappagari [États-Unis] ; Pravin T. P. Kaumaya [États-Unis]	Synthetic peptides as cancer vaccines
000D39 (2002)	K. Sadler [Australie] ; W. Zeng [Australie] ; D. C. Jackson [Australie]	Synthetic peptide epitope‐based polymers: controlling size and determining the efficiency of epitope incorporation
000E26 (2001)	Masha Fridkis-Hareli [États-Unis] ; Joel N. H Stern [États-Unis] ; Lars Fugger [Danemark] ; Jack L. Strominger [États-Unis]	Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses
000E27 (2001)	K. M. Skubitz [États-Unis] ; K. D. Campbell [États-Unis] ; A. P. N. Skubitz [États-Unis]	Synthetic peptides from the N‐domains of CEACAMs activate neutrophils
000E97 (2001)	Wolfgang Zauner ; Karen Lingnau ; Frank Mattner ; Alexander Von Gabain ; Michael Buschle	Defined Synthetic Vaccines
000F88 (2000)	Masha Fridkis-Hareli ; Edward F. Rosloniec ; Lars Fugger ; Jack L. Strominger [États-Unis]	Synthetic peptides that inhibit binding of the collagen type II 261–273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses
000F89 (2000)	M. Egli [États-Unis] ; S. M. Gryaznov [États-Unis]	Synthetic oligonucleotides as RNA mimetics: 2′-modified RNAs and N3′→P5′ phosphoramidates
001188 (1999)	Karl A. Haushalter [États-Unis] ; P. Todd Stukenberg [États-Unis] ; Marc W. Kirschner [États-Unis] ; Gregory L. Verdine [États-Unis]	Identification of a new uracil-DNA glycosylase family by expression cloning using synthetic inhibitors

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "synthetic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "synthetic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    synthetic
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021